Embecta (FRA:JX7) ROE % Adjusted to Book Value : Negative Equity% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta ROE % Adjusted to Book Value?

Embecta's ROE % for the quarter that ended in Mar. 2024 was Negative Equity. Embecta's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Embecta's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was Negative Equity.

Embecta ROE % Adjusted to Book Value Historical Data

The historical data trend for Embecta's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta ROE % Adjusted to Book Value Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

ROE % Adjusted to Book Value

Negative Equity

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											Negative Equity	Negative Equity	Negative Equity	Negative Equity	Negative Equity

Competitive Comparison of Embecta's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Embecta's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embecta's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Embecta's ROE % Adjusted to Book Value falls into.

Embecta ROE % Adjusted to Book Value Calculation

Embecta's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Embecta's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Embecta ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Embecta's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines